Contingency Management to Reinforce Attendance to Cognitive Behavioral Treatment for Gambling Disorder
Launched by EAST TENNESSEE STATE UNIVERSITY · Jun 3, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help people with gambling problems by combining a popular therapy called Cognitive Behavioral Therapy (CBT) with something called contingency management (CM). CM is a method that rewards individuals for attending therapy sessions and engaging in recovery activities with a peer support specialist. The goal is to see if these incentives can help more people stick with their treatment and improve their chances of recovery.
To be eligible for this trial, participants need to be at least 18 years old and seeking help for their gambling issues at The Gambling Clinic. They should be able to attend weekly sessions for eight weeks and be comfortable communicating in English. Unfortunately, individuals with recent severe mental health issues or those looking for treatment for someone else cannot participate. If you join, you can expect to attend regular therapy sessions and receive rewards for your commitment to the program, which aims to provide better support for overcoming gambling disorder.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults age 18 or older
- • 2. Seeking treatment for gambling-related concerns at The Gambling Clinic
- • 3. Available to meet weekly for eight treatment sessions without a known structural barrier to continuation that could interfere with study conclusions (e.g., planned relocation out of state).
- • 4. Proficient in English (assumed by request of gambling treatment in English).
- • 5. Must be physically present in the US.
- Exclusion Criteria:
- • 1. Minors under the age of 18.
- • 2. Recent history of psychotic symptoms or suicidal intent
- • 3. Not proficient in English.
- • 4. Seeking gambling treatment for someone other than themselves (e.g., a loved one).
- • 5. Will not be available for a full eight weeks of study participation.
- • 6. Not physically present in the US.
About East Tennessee State University
East Tennessee State University (ETSU) is a distinguished public research institution committed to advancing healthcare through innovative clinical trials and research initiatives. With a focus on improving patient outcomes and addressing pressing health challenges, ETSU leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical investigations. The university's dedicated team of researchers and healthcare professionals collaborate with local and national partners, ensuring adherence to ethical standards and regulatory compliance. Through its commitment to education and community service, ETSU plays a vital role in translating research findings into effective treatments and interventions, ultimately enhancing the health and well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Johnson City, Tennessee, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported